研究生: |
黃惠仙 |
---|---|
論文名稱: |
金柑對年輕女性血脂、抗氧化性與雌激素代謝之影響 The effects of Kumquat ingestion on blood lipids, antioxidant status and estrogen metabolites in young women |
指導教授: | 吳文惠 |
學位類別: |
碩士 Master |
系所名稱: |
人類發展與家庭學系 Department of Human Development and Family Studies |
論文出版年: | 2006 |
畢業學年度: | 94 |
語文別: | 中文 |
論文頁數: | 94 |
中文關鍵詞: | 金柑 、類黃酮 、檸檬油精(薴烯) 、血脂 、抗氧化 、雌激素代謝 |
論文種類: | 學術論文 |
相關次數: | 點閱:237 下載:21 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
宜蘭縣的特產水果金柑,其果皮富含多種類黃酮物質與d-limonene,金柑的特點是可以連皮一起攝取,本研究目的在探討每日食用金柑,對於婦女血脂、抗氧化能力、與雌激素代謝之影響。採交叉試驗,將23位受試者(19-27歲)隨機分為兩組,一組先食用金柑,每天30克(約12~14顆) 於餐後食用,持續一個月經週期,而在下一個月經週期食用習慣飲食,另一組次序則相反。所有受試者以月經來後第6-8天為開始日,分別於參與研究前及兩期終了時抽血與收集晨尿共三次,分析血脂、isoprostane、尿鈣、雌激素代謝與LDL氧化。研究期間受試者體重、體脂肪、BMI與熱量攝取皆保持不變,結果經重複量數共變數分析(ANCOVA)校正體重與前測數值,以攝取金柑後的數值與習慣飲食相比,發現血漿中LDL-C以及LDL-C/HDL-C在分別降低了7.69%(p<0.05)與8.29%(p<0.05),但血漿中總膽固醇、HDL-C與三酸甘油酯沒有顯著差異;血清總抗氧化狀態近於顯著增加5.66%(p=0.058),但LDL氧化遲滯期、TBARS產生量與尿液雌激素代謝物分佈的變化,則未有顯著差異。推論本研究結果年輕女性每日攝取30克金柑,在持續一個月經週期食用之下,可以降低血漿中LDL膽固醇,且也許有增加抗氧化能力之潛力。
Kumquat (Fortunella) is a special fruit consumed with peel which contains high concentrations of flavonoids and d-limonene. This study is aimed to examine the effect of Kumquat consumption on levels of blood lipids, LDL oxidation, serum isoprostane and urinary estrogen metabolites. Using a cross-over design, 23 young women (age of 18-27) were randomly divided into two groups. One group took 30 g of kumquat per day for 1 menstrual cycle and then followed by their habitual diet for another menstrual cycle. The other group completed the same treatment in reverse order. Each subject started at the 6th-8th day of menstrual period. Blood and first morning urine samples were collected at baseline, the ends of habitual diet and the kumquat intervention period. Results were analyzed by ANCOVA, controlled for baseline and weight. Body weight, percent of body fat, body mass index and energy intake did not change during this trial. The levels of plasma LDL-C and LDL-C/HDL-C decreased by 7.69% and 8.29%, respectively, after kumquat and were significantly different from those after habitual diet (p<0.05). The serum total antioxidant status after kumquat increased with borderline significance (p= 0.058) as compared with that after habitual diet. No significant difference was found in the levels of plasma cholesterol, HDL-C, serum isoprostane, estradiol, lag time of LDL oxidation, LDL-TBARS, and urinary estrogen metabolites. In conclusion, kumquat intake at a dose of 30 g per day for one menstruation cycle decreases plasma LDL-C, and might possibly increase antioxidant status in young women.
【中文部分】
行政院衛生署中醫藥委員會(2003) 台灣藥用植物資源名錄。行政院衛生署中醫藥委員會。
林瑞雯(2002) 金柑全果系果汁降低苦味與改善黏稠度之研究。國立臺灣大學園藝學研究所碩士論文。
食品工業發展研究所、屏東科技大學(1998) 台灣地區食品營養成分資料庫。行政院衛生署。
晏文潔、李家璞、杜平直(2000) 類黃酮抗氧化力與其結構之關係。臺灣農業化學與食品科學38(1):80-88。
張蘭昌(1981) 中藥大辭典。昭人出版社。
莊月雀(2004) 台灣產柑橘類果實機能性成分之研究。國立中興大學食品科學系碩士論文。
楊恭毅(1984) 楊氏園藝植物大名典。中國花卉雜誌社。
Guyton, A. C. (1982) Guyton's生理學 (賈皓琪、劉明威、洪貽樂、林森田和覃康定譯,二版)。合記圖書出版社。.
【英文部分】
Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., & Hamalainen, E. (1994). Estrogen metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst, 86(14), 1076-1082.
Asamoto, M., Ota, T., Toriyama-Baba, H., Hokaiwado, N., Naito, A., & Tsuda, H. (2002). Mammary carcinomas induced in human c-ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res, 93(1), 32-35.
Aviram, M. (1995). Ldl-platelet interaction under oxidative stress induces macrophage foam cell formation. Thromb Haemost, 74(1), 560-564.
Bailey, H. H., Levy, D., Harris, L. S., Schink, J. C., Foss, F., Beatty, P., et al. (2002). A phase ii trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern cooperative oncology group study e2e96. Gynecol Oncol, 85(3), 464-468.
Bain, C. A., Lees, K. R., Lumsden, M. A., & Walters, M. R. (2005). Effect of a gonadotropin releasing hormone analog on cerebral hemodynamics in premenopausal women. Climacteric, 8(2), 193-197.
Bardon, S., Picard, K., & Martel, P. (1998). Monoterpenes inhibit cell growth, cell cycle progression, and cyclin d1 gene expression in human breast cancer cell lines. Nutr Cancer, 32(1), 1-7.
Benavente-Garcı´a, O., Castillo, J. n., Marin, F. R., o, A. O., & Rı´o, J. A. D. (1997). Uses and properties of citrus flavonoids. J Agri Food Chem, 45, 4505-4515.
Bentz, A. T., Schneider, C. M., & Westerlind, K. C. (2005). The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (united states). Cancer Causes Control, 16(4), 455-461.
Bok, S. H., Lee, S. H., Park, Y. B., Bae, K. H., Son, K. H., Jeong, T. S., et al. (1999). Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-coa reductase and acyl coa: Cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr, 129(6), 1182-1185.
Bonorden, M. J., Greany, K. A., Wangen, K. E., Phipps, W. R., Feirtag, J., Adlercreutz, H., et al. (2004). Consumption of lactobacillus acidophilus and bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr, 58(12), 1635-1642.
Bowry, V. W., & Stocker, R. (1993). Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin e on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc., 115, 6029-6044.
Bradlow, H. L., Hershcopf, R. J., Martucci, C. P., & Fishman, J. (1985). Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A, 82(18), 6295-6299.
Breinholt, V., & Larsen, J. C. (1998). Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified mcf7 cell proliferation assay. Chem Res Toxicol, 11(6), 622-629.
Breithofer, A., Graumann, K., Scicchitano, M. S., Karathanasis, S. K., Butt, T. R., & Jungbauer, A. (1998). Regulation of human estrogen receptor by phytoestrogens in yeast and human cells. J Steroid Biochem Mol Biol, 67(5-6), 421-429.
Calliste, C. A., Le Bail, J. C., Trouillas, P., Pouget, C., Habrioux, G., Chulia, A. J., et al. (2001). Chalcones: Structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res, 21(6A), 3949-3956.
Campbell, K. L., Westerlind, K. C., Harber, V. J., Friedenreich, C. M., & Courneya, K. S. (2005). Associations between aerobic fitness and estrogen metabolites in premenopausal women. Med Sci Sports Exerc, 37(4), 585-592.
Casaschi, A., Maiyoh, G. K., Rubio, B. K., Li, R. W., Adeli, K., & Theriault, A. G. (2004). The chalcone xanthohumol inhibits triglyceride and apolipoprotein b secretion in hepg2 cells. J Nutr, 134(6), 1340-1346.
Cesarone, M. R., Laurora, G., De Sanctis, M. T., & Belcaro, G. (1993). Capillary filtration and ankle edema in patients with venous hypertension: Effects of daflon. Angiology, 44(1), 57-61.
Chiang, A. N., & Huang, P. C. (1984). Effects of foods rich in dietary fiber on lipid metabolism in rats. Taiwan Yi Xue Hui Za Zhi, 83(5), 405-412.
Choi, H. S. (2005). Characteristic odor components of kumquat (fortunella japonica swingle) peel oil. J Agric Food Chem, 53(5), 1642-1647.
Chow, H. H., Salazar, D., & Hakim, I. A. (2002). Pharmacokinetics of perillic acid in humans after a single dose administration of a citrus preparation rich in d-limonene content. Cancer Epidemiol Biomarkers Prev, 11(11), 1472-1476.
Clegg, R. J., Middleton, B., Bell, G. D., & White, D. A. (1982). The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase in vivo in the rat. J Biol Chem, 257(5), 2294-2299.
Coker, A. L., Crane, M. M., Sticca, R. P., & Sepkovic, D. W. (1997). Re: Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst, 89(1), 89-90.
Crespy, V., Aprikian, O., Morand, C., Besson, C., Manach, C., Demigne, C., et al. (2001a). Bioavailability of phloretin and phloridzin in rats. J Nutr, 131(12), 3227-3230.
Crespy, V., Morand, C., Besson, C., Manach, C., Demigne, C., & Remesy, C. (2001b). Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. J Nutr, 131(8), 2109-2114.
Crowell, P. L. (1997). Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat, 46(2-3), 191-197.
Crowell, P. L., Chang, R. R., Ren, Z. B., Elson, C. E., & Gould, M. N. (1991). Selective inhibition of isoprenylation of 21-26-kda proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem, 266(26), 17679-17685.
Crowell, P. L., Elson, C. E., Bailey, H. H., Elegbede, A., Haag, J. D., & Gould, M. N. (1994a). Human metabolism of the experimental cancer therapeutic agent d-limonene. Cancer Chemother Pharmacol, 35(1), 31-37.
Crowell, P. L., Hoesly, J. D., Vedejs, E., Ahmed, S., & Gould, M. N. (1989). Metabolism of limonene in rats. Increaseed inhibition of mammary tumorigenesis by a hydroxylated metabolite. Proc Am Assoc Cancer Res, 30, 171.
Crowell, P. L., Lin, S., Vedejs, E., & Gould, M. N. (1992). Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol, 31(3), 205-212.
Crowell, P. L., Ren, Z., Lin, S., Vedejs, E., & Gould, M. N. (1994b). Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol, 47(8), 1405-1415.
Day, A. J., Canada, F. J., Diaz, J. C., Kroon, P. A., McLauchlan, R., Faulds, C. B., et al. (2000). Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett, 468(2-3), 166-170.
De Cree, C., Ball, P., Seidlitz, B., Van Kranenburg, G., Geurten, P., & Keizer, H. A. (1997). Effects of a training program on resting plasma 2-hydroxycatecholestrogen levels in eumenorrheic women. J Appl Physiol, 83(5), 1551-1556.
Elegbede, J. A., Elson, C. E., Qureshi, A., Tanner, M. A., & Gould, M. N. (1984). Inhibition of dmba-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis, 5(5), 661-664.
Elegbede, J. A., Elson, C. E., Tanner, M. A., Qureshi, A., & Gould, M. N. (1986). Regression of rat primary mammary tumors following dietary d-limonene. J Natl Cancer Inst, 76(2), 323-325.
Elson, C. E., Maltzman, T. H., Boston, J. L., Tanner, M. A., & Gould, M. N. (1988). Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of dmba-induced rat mammary carcinogenesis. Carcinogenesis, 9(2), 331-332.
Endo, A., Tsujita, Y., Kuroda, M., & Tanzawa, K. (1979). Effects of ml-236b on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta, 575(2), 266-276.
Erlund, I., Meririnne, E., Alfthan, G., & Aro, A. (2001). Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr, 131(2), 235-241.
Falk, R. T., Fears, T. R., Xu, X., Hoover, R. N., Pike, M. C., Wu, A. H., et al. (2005). Urinary estrogen metabolites and their ratio among asian american women. Cancer Epidemiol Biomarkers Prev, 14(1), 221-226.
Figtree, G. A., Griffiths, H., Lu, Y. Q., Webb, C. M., MacLeod, K., & Collins, P. (2000). Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol, 35(7), 1977-1985.
Fishman, J., & Martucci, C. (1980). Biological properties of 16 alpha-hydroxyestrone: Implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab, 51(3), 611-615.
Fishman, J., Boyar, R. M., & Hellman, L. (1975). Influence of body weight on estradiol metabolism in young women. J Clin Endocrinol Metab, 41(5), 989-991.
Fishman, J., Schneider, J., Hershcope, R. J., & Bradlow, H. L. (1984). Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer. J Steroid Biochem, 20(4B), 1077-1081.
Franke, A. A., Cooney, R. V., Henning, S. M., & Custer, L. J. (2005). Bioavailability and antioxidant effects of orange juice components in humans. J Agric Food Chem, 53(13), 5170-5178.
Gelb, M. H., Tamanoi, F., Yokoyama, K., Ghomashchi, F., Esson, K., & Gould, M. N. (1995). The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett, 91(2), 169-175.
Ghiselli, A., Serafini, M., Natella, F., & Scaccini, C. (2000). Total antioxidant capacity as a tool to assess redox status: Critical view and experimental data. Free Radic Biol Med, 29(11), 1106-1114.
Gorinstein, S., Leontowicz, H., Leontowicz, M., Krzeminski, R., Gralak, M., Delgado-Licon, E., et al. (2005). Changes in plasma lipid and antioxidant activity in rats as a result of naringin and red grapefruit supplementation. J Agric Food Chem, 53(8), 3223-3228.
Gorinstein, S., Leontowicz, H., Leontowicz, M., Krzeminski, R., Gralak, M., Martin-Belloso, O., et al. (2004). Fresh israeli jaffa blond (shamouti) orange and israeli jaffa red star ruby (sunrise) grapefruit juices affect plasma lipid metabolism and antioxidant capacity in rats fed added cholesterol. J Agric Food Chem, 52(15), 4853-4859.
Guyton, A. C. (1986). Textbook of medical physiology (7 ed.). Philadelphia: Saunders.
Haag, J. D., Lindstrom, M. J., & Gould, M. N. (1992). Limonene-induced regression of mammary carcinomas. Cancer Res, 52(14), 4021-4026.
Herencia, F., Ferrandiz, M. L., Ubeda, A., Guillen, I., Dominguez, J. N., Charris, J. E., et al. (1999). Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett, 453(1-2), 129-134.
Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., et al. (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med, 155(4), 381-386.
Ho, G. H., Luo, X. W., Ji, C. Y., Foo, S. C., & Ng, E. H. (1998). Urinary 2/16 alpha-hydroxyestrone ratio: Correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore, 27(2), 294-299.
Hudes, G. R., Szarka, C. E., Adams, A., Ranganathan, S., McCauley, R. A., Weiner, L. M., et al. (2000). Phase i pharmacokinetic trial of perillyl alcohol (nsc 641066) in patients with refractory solid malignancies. Clin Cancer Res, 6(8), 3071-3080.
Jernstrom, H., Klug, T. L., Sepkovic, D. W., Bradlow, H. L., & Narod, S. A. (2003). Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis, 24(5), 991-1005.
Kabat, G. C., Chang, C. J., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A., et al. (1997). Urinary estrogen metabolites and breast cancer: A case-control study. Cancer Epidemiol Biomarkers Prev, 6(7), 505-509.
Kawaii, S., Tomono, Y., Katase, E., Ogawa, K., & Yano, M. (1999). Quantitation of flavonoid constituents in citrus fruits. J Agric Food Chem, 47(9), 3565-3571.
Kjonaas, R., & Croteau, R. (1983). Demonstration that limonene is the first cyclic intermediate in the biosynthesis of oxygenated p-menthane monoterpenes in mentha piperita and other mentha species. Arch Biochem Biophys, 220(1), 79-89.
Kostner, G. M., Gavish, D., Leopold, B., Bolzano, K., Weintraub, M. S., & Breslow, J. L. (1989). Hmg coa reductase inhibitors lower ldl cholesterol without reducing lp(a) levels. Circulation, 80(5), 1313-1319.
Koyasako, A., & Bernhard, R. A. (1983). Volatile constituents of the essential oil of kumquat. J Food Sci, 48, 1807-1812.
Kumamoto, H., Matsubara, Y., Iizuka, Y., Okamoto, K., & Yokoi, K. (1985). Structure and hypotensive effect of flavonoid glycosides in kinkan(fortunella japonica) peelings. Agric Biol Chem, 49(9), 2613-2618.
Kumar, N. B., Cantor, A., Allen, K., Riccardi, D., & Cox, C. E. (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer, 94(4), 1166-1174.
Kurowska, E. M., & Manthey, J. A. (2004). Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J Agric Food Chem, 52(10), 2879-2886.
Maltese, W. A., Defendini, R., Green, R. A., Sheridan, K. M., & Donley, D. K. (1985). Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. J Clin Invest, 76(5), 1748-1754.
Maltzman, T. H., Hurt, L. M., Elson, C. E., Tanner, M. A., & Gould, M. N. (1989). The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis, 10(4), 781-783.
Mateos, R., Lecumberri, E., Ramos, S., Goya, L., & Bravo, L. (2005). Determination of malondialdehyde (mda) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci.
Meilahn, E. N., De Stavola, B., Allen, D. S., Fentiman, I., Bradlow, H. L., Sepkovic, D. W., et al. (1998). Do urinary oestrogen metabolites predict breast cancer? Guernsey iii cohort follow-up. Br J Cancer, 78(9), 1250-1255.
Meyer, O. C. (1994). Safety and security of daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology, 45(6 Pt 2), 579-584.
Michnovicz, J. J., & Bradlow, H. L. (1991). Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer, 16(1), 59-66.
Michnovicz, J. J., Adlercreutz, H., & Bradlow, H. L. (1997). Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst, 89(10), 718-723.
Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986). Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med, 315(21), 1305-1309.
Miksicek, R. J. (1995). Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Biol Med, 208(1), 44-50.
Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M., Frei, B., Deinzer, M. L., et al. (2000). Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem, 48(9), 3876-3884.
Miyazawa, M., Shindo, M., & Shimada, T. (2002). Sex differences in the metabolism of (+)- and (-)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome p450 enzymes in rat liver microsomes. Chem Res Toxicol, 15(1), 15-20.
Morrow, J. D., & Roberts, L. J., 2nd. (1996). The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol, 51(1), 1-9.
Morrow, J. D., Minton, T. A., Mukundan, C. R., Campbell, M. D., Zackert, W. E., Daniel, V. C., et al. (1994). Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of d-ring and e-ring isoprostanes. J Biol Chem, 269(6), 4317-4326.
Muti, P., Bradlow, H. L., Micheli, A., Krogh, V., Freudenheim, J. L., Schunemann, H. J., et al. (2000). Estrogen metabolism and risk of breast cancer: A prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology, 11(6), 635-640.
Nachtigall, L. E. (1999). Sex hormone-binding globulin and breast cancer risk. Primary Care Update for OB/GYNS, 6(2), 39-45.
Ogawa, H., Ohno, M., & Baba, K. (2005). Hypotensive and lipid regulatory actions of 4-hydroxyderricin, a chalcone from angelica keiskei, in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol, 32(1-2), 19-23.
Ogawa, K., Kawasaki, A., Omura, M., Yoshida, T., Ikoma, Y., & Yano, M. (2001). 3',5'-di-c-beta-glucopyranosylphloretin, a flavonoid characteristic of the genus fortunella. Phytochemistry, 57(5), 737-742.
O'Reilly, J. D., Mallet, A. I., McAnlis, G. T., Young, I. S., Halliwell, B., Sanders, T. A., et al. (2001). Consumption of flavonoids in onions and black tea: Lack of effect on f2-isoprostanes and autoantibodies to oxidized ldl in healthy humans. Am J Clin Nutr, 73(6), 1040-1044.
Panini, S. R., Delate, T. A., & Sinensky, M. (1992). Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase by 24(s),25-oxidolanosterol. J Biol Chem, 267(18), 12647-12654.
Phillips, L. R., Malspeis, L., & Supko, J. G. (1995). Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. Drug Metab Dispos, 23(7), 676-680.
Poon, G. K., Vigushin, D., Griggs, L. J., Rowlands, M. G., Coombes, R. C., & Jarman, M. (1996). Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry. Drug Metab Dispos, 24(5), 565-571.
Qureshi, A., Mangels, W. R., Din, Z. Z., & Elson, C. E. (1988). Inhibition of hepatic mevalonate biosynthesis by the monoterpene, d -limonene. J Agric Food Chem, 36, 1220-1224.
Regan, J. W., & Bjeldanes, L. F. (1976). Metabolism of (+)-limonene in rats. J Agric Food Chem, 24(2), 377-380.
Reicks, M. M., & Crankshaw, D. (1993). Effects of d-limonene on hepatic microsomal monooxygenase activity and paracetamol-induced glutathione depletion in mouse. Xenobiotica, 23(7), 809-819.
Ren, Z., & Gould, M. N. (1994). Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Lett, 76(2-3), 185-190.
Ripple, G. H., Gould, M. N., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Simon, K., et al. (2000). Phase i clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res, 6(2), 390-396.
Ripple, G. H., Gould, M. N., Stewart, J. A., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., et al. (1998). Phase i clinical trial of perillyl alcohol administered daily. Clin Cancer Res, 4(5), 1159-1164.
Rojas, J., Dominguez, J. N., Charris, J. E., Lobo, G., Paya, M., & Ferrandiz, M. L. (2002). Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase. Eur J Med Chem, 37(8), 699-705.
Sawamura, M., Thi Minh Tu, N., Onishi, Y., Ogawa, E., & Choi, H. S. (2004). Characteristic odor components of citrus reticulata blanco (ponkan) cold-pressed oil. Biosci Biotechnol Biochem, 68(8), 1690-1697.
Schisterman, E. F., Faraggi, D., Browne, R., Freudenheim, J., Dorn, J., Muti, P., et al. (2001). Tbars and cardiovascular disease in a population-based sample. J Cardiovasc Risk, 8(4), 219-225.
Schneider, J., Bradlow, H. L., Strain, G., Levin, J., Anderson, K., & Fishman, J. (1983). Effects of obesity on estradiol metabolism: Decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab, 56(5), 973-978.
Shirley, B. W. (1996). Flavonoid biosynthesis: 'new' functions for an 'old' pathway. Trends Plant Sci, 1(11), 377-382.
Snow, R. C., Barbieri, R. L., & Frisch, R. E. (1989). Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab, 69(2), 369-376.
Song, H. S., Lan Phi, N. T., Park, Y. H., & Sawamura, M. (2006). Volatile profiles in cold-pressed peel oil from korean and japanese shiranui (citrus unshiu marcov. X c. Sinensis osbeck x c. Reticulata blanco). Biosci Biotechnol Biochem, 70(3), 737-739.
Sonnichsen, A. C., Ritter, M. M., Mohrle, W., Richter, W. O., & Schwandt, P. (1993). The waist-to-hip ratio corrected for body mass index is related to serum triglycerides and high-density lipoprotein cholesterol but not to parameters of glucose metabolism in healthy premenopausal women. Clin Investig, 71(11), 913-917.
Sowers, M., & Sigler, C. (1999). Complex relation between increasing fat mass and decreasing high density lipoprotein cholesterol levels: Evidence from a population-based study of premenopausal women. Am J Epidemiol, 149(1), 47-54.
Struckmann, J. R., & Nicolaides, A. N. (1994). Flavonoids. A review of the pharmacology and therapeutic efficacy of daflon 500 mg in patients with chronic venous insufficiency and related disorders. Angiology, 45(6), 419-428.
Taioli, E., Garte, S. J., Trachman, J., Garbers, S., Sepkovic, D. W., Osborne, M. P., et al. (1996). Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst, 88(9), 617.
Takahashi, Y., Inaba, N., Kuwahara, S., & Kuki, W. (2003). Antioxidative effect of citrus essential oil components on human low-density lipoprotein in vitro. Bioscience, Biotechnology & Biochemistry, 67(1), 195-197.
Telang, N. T., Suto, A., Wong, G. Y., Osborne, M. P., & Bradlow, H. L. (1992). Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst, 84(8), 634-638.
Tsouderos, Y. (1991). Venous tone: Are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with daflon 500 mg. Z Kardiol, 80 Suppl 7, 95-101.
Uedo, N., Tatsuta, M., Iishi, H., Baba, M., Sakai, N., Yano, H., et al. (1999). Inhibition by d-limonene of gastric carcinogenesis induced by n-methyl-n'-nitro-n-nitrosoguanidine in wistar rats. Cancer Lett, 137(2), 131-136.
Umano, K., Ha, Y., Tamura, T., Shoji, A., & Shibamoto, T. (1994). Identification of volatile compounds isolated from round kumquat(fortunella japonica swingle). J Agric Food Chem, 42, 1888-1890.
Upston, J. M., Terentis, A. C., & Stocker, R. (1999). Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin e as a potential antiatherogenic supplement. Faseb J, 13(9), 977-994.
Ursin, G., London, S., Stanczyk, F. Z., Gentzschein, E., Paganini-Hill, A., Ross, R. K., et al. (1999). Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst, 91(12), 1067-1072.
Ursin, G., London, S., Yang, D., Tseng, C. C., Pike, M. C., Bernstein, L., et al. (2002). Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Res Treat, 72(2), 139-143.
Verzera, A., Trozzi, A., Zappala, M., Condurso, C., & Cotroneo, A. (2005). Essential oil composition of citrus meyerii y. Tan. And citrus medica l. Cv. Diamante and their lemon hybrids. J Agric Food Chem, 53(12), 4890-4894.
Vigushin, D. M., Poon, G. K., Boddy, A., English, J., Halbert, G. W., Pagonis, C., et al. (1998). Phase i and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer research campaign phase i/ii clinical trials committee. Cancer Chemother Pharmacol, 42(2), 111-117.
Vossen, R. C., van Dam-Mieras, M. C., Hornstra, G., & Zwaal, R. F. (1993). Continuous monitoring of lipid peroxidation by measuring conjugated diene formation in an aqueous liposome suspension. Lipids, 28(9), 857-861.
Wagner, J. E., Huff, J. L., Rust, W. L., Kingsley, K., & Plopper, G. E. (2002). Perillyl alcohol inhibits breast cell migration without affecting cell adhesion. J Biomed Biotechnol, 2(3), 136-140.
Wang, G., Kuan, S. S., Francis, O. J., Ware, G. M., & Carman, A. S. (1990). A simplified hplc method for the determination of phytoestrogens in soybean and its processeds products. J Agri Food Chem, 38, 185-190.
Wattenberg, L. W., Coccia, J. B., & Galbraith, A. R. (1994). Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett, 83(1-2), 165-169.
Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2001). Secretion of hepatocyte apob is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of acat2 and mtp. J Lipid Res, 42(5), 725-734.
Willcox, J. K., Catignani, G. L., & Roberts, L. J., 2nd. (2003). Dietary flavonoids fail to suppress f2-isoprostane formation in vivo. Free Radic Biol Med, 34(7), 795-799.
Wiseman, H., O'Reilly, J. D., Adlercreutz, H., Mallet, A. I., Bowey, E. A., Rowland, I. R., et al. (2000). Isoflavone phytoestrogens consumed in soy decrease f(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr, 72(2), 395-400.
Xu, X., Duncan, A. M., Merz, B. E., & Kurzer, M. S. (1998). Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev, 7(12), 1101-1108.
Zheng, G. Q., Kenney, P. M., & Lam, L. K. (1992). Anethofuran, carvone, and limonene: Potential cancer chemopreventive agents from dill weed oil and caraway oil. Planta Med, 58(4), 338-341.